cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.15468/dl.2vcfby
title: Occurrence Download

description: A dataset containing 26943 species occurrences available in GBIF matching the query:
{
 "and" : [
 "HasGeospatialIssue is false",
 "HasCoordinate is true",
 "OccurrenceStatus is Present",
 "BasisOfRecord is one of (Human Observation, Machine Observation, Occurrence evidence, Observation)",
 "TaxonKey is one of (Pardirallus nigricans)",
 "Country is one of (Anguilla, Antigua and Barbuda, Argentina, Aruba, Bahamas, Barbados, Belize, Bolivia (Plurinational State of), Bonaire, Sint Eustatius and Saba, Bouvet Island, Brazil, Cayman Islands, Chile, Colombia, Costa Rica, Cuba, Curaçao, Dominica, Dominican Republic, Ecuador, El Salvador, Falkland Islands (Malvinas), French Guiana, Grenada, Guadeloupe, Guatemala, Guyana, Haiti, Honduras, Jamaica, Martinique, Mexico, Montserrat, Nicaragua, Panama, Paraguay, Peru, Puerto Rico, Saint Barthélemy, Saint Kitts and Nevis, Saint Lucia, Saint Martin (French part), Saint Vincent and the Grenadines, Sint Maarten (Dutch part), South Georgia and the South Sandwich Islands, Suriname, Trinidad and Tobago, Turks and Caicos Islands, Uruguay, Venezuela (Bolivarian Republic of), Virgin Islands (British), Virgin Islands (U.S.))"
 ]
}

 The dataset includes 26943 records from 25 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0078747-250717081556266/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.5bxruh
title: Occurrence Download

description: A dataset containing 0 species occurrences available in GBIF matching the query:
{
 "and" : [
 "HasGeospatialIssue is false",
 "HasCoordinate is true",
 "OccurrenceStatus is Present",
 "BasisOfRecord is one of (Human Observation, Machine Observation, Occurrence evidence, Observation)",
 "TaxonKey is one of (Pardirallus nigricans)",
 "Country is one of (Afghanistan, Armenia, Azerbaijan, Bahrain, Bangladesh, Bhutan, Brunei Darussalam, Cambodia, China, Cyprus, Georgia, Hong Kong, India, Indonesia, Iran (Islamic Republic of), Iraq, Israel, Japan, Jordan, Kazakhstan, Korea (Democratic People’s Republic of), Korea, Republic of, Kuwait, Kyrgyzstan, Lao People’s Democratic Republic, Lebanon, Macao, Malaysia, Maldives, Mongolia, Myanmar, Nepal, Oman, Pakistan, Palestine, State of, Philippines, Qatar, Saudi Arabia, Singapore, Sri Lanka, Syrian Arab Republic, Tajikistan, Thailand, Timor-Leste, Türkiye, Turkmenistan, United Arab Emirates, Uzbekistan, Viet Nam, Yemen)"
 ]
}

 The dataset includes 0 records from 0 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0078745-250717081556266/datasets/export for details.
DOI: 10.6084/m9.figshare.29712857
title: Supplementary Material for: Protocol of the comparison of two different bicarbonate replacement fluids during CVVH with RCA: a Prospective, Randomized, Controlled Trial

description: Background: Acid-base disturbances are common issues during continuous veno-venous hemofiltration (CVVH). Especially using regional citrate anticoagulation (RCA) recent studies have shown that control in intracorporal pH and HCO3- concentration may be improved when the replacement fluid is changed to a solution with a lower HCO3- concentration during continuous renal replacement therapy (CRRT). This prospective trail aims to compare acid base balance between a high (HBF) and low (LBF) bicarbonate replacement fluid over a period of 96 hours after CVVH initiation using RCA.
Methods/ design: This is a prospective, randomized, controlled, open-label, cross-over, Phase II, single-centre pilot study involving critically ill patients requiring RRT. The two replacement fluids (Phoxilium and Biphozyl) are compared in two groups with 1:1 block randomization and consecutive crossover after 48 hours of CVVH. The primary endpoints are the occurrence of at least one pH (&gt; 7.45) or HCO3- (&gt; 26 mmol/l) excursion within 16-48 hours of each treatment phase using a Generalized Estimating Equation (GEE) approach.
Primary objective: The objective is to examine differences of pH and HCO3- between patients who receive LBF and HBF as replacement fluid during CVVH.
Hypothesis: We hypothesize that during CVVH with LBF, pH and HCO3- excursion rates are significantly lower compared to HBF.
Trial status: Recruitment of 88 study participants is ongoing, with the trial expected to be completed in 2025. Data cleaning, analysis, and publication preparation will follow thereafter.
Discussion: Given the broad inclusion and restricted exclusion criteria, we expect the results of the BiPhox-Trial to be broadly applicable to patients in need of CVVH with RCA in the intensive care setting. This trial aims to determine whether the use of LBF results in more stable acid-base parameters compared to HBF during CVVH with RCA in critically ill patients, and may guide therapeutic decisions in clinical practice.
DOI: 10.6084/m9.figshare.29712857.v1
title: Supplementary Material for: Protocol of the comparison of two different bicarbonate replacement fluids during CVVH with RCA: a Prospective, Randomized, Controlled Trial

description: Background: Acid-base disturbances are common issues during continuous veno-venous hemofiltration (CVVH). Especially using regional citrate anticoagulation (RCA) recent studies have shown that control in intracorporal pH and HCO3- concentration may be improved when the replacement fluid is changed to a solution with a lower HCO3- concentration during continuous renal replacement therapy (CRRT). This prospective trail aims to compare acid base balance between a high (HBF) and low (LBF) bicarbonate replacement fluid over a period of 96 hours after CVVH initiation using RCA.
Methods/ design: This is a prospective, randomized, controlled, open-label, cross-over, Phase II, single-centre pilot study involving critically ill patients requiring RRT. The two replacement fluids (Phoxilium and Biphozyl) are compared in two groups with 1:1 block randomization and consecutive crossover after 48 hours of CVVH. The primary endpoints are the occurrence of at least one pH (&gt; 7.45) or HCO3- (&gt; 26 mmol/l) excursion within 16-48 hours of each treatment phase using a Generalized Estimating Equation (GEE) approach.
Primary objective: The objective is to examine differences of pH and HCO3- between patients who receive LBF and HBF as replacement fluid during CVVH.
Hypothesis: We hypothesize that during CVVH with LBF, pH and HCO3- excursion rates are significantly lower compared to HBF.
Trial status: Recruitment of 88 study participants is ongoing, with the trial expected to be completed in 2025. Data cleaning, analysis, and publication preparation will follow thereafter.
Discussion: Given the broad inclusion and restricted exclusion criteria, we expect the results of the BiPhox-Trial to be broadly applicable to patients in need of CVVH with RCA in the intensive care setting. This trial aims to determine whether the use of LBF results in more stable acid-base parameters compared to HBF during CVVH with RCA in critically ill patients, and may guide therapeutic decisions in clinical practice.
DOI: 10.6084/m9.figshare.29712863
title: Supplementary Material for: Pyodermatitis-Pyostomatitis Vegetans with eyelid Involvement: A Rare Manifestation in a Patient with Ulcerative Colitis

description: Pyodermatitis-pyostomatitis vegetans (PDV-PSV) is a rare and chronic mucocutaneous inflammatory disorder strongly associated with inflammatory bowel disease (IBD), particularly ulcerative colitis (UC). It typically presents with exudative plaques that may affect the face, scalp, and intertriginous areas and also pustular lesions on the oral mucosa. Although several cases with cutaneous and mucosal involvement have been reported, Eyelid involvement remains uncommon and sparsely reported in the literature.
We report a 28-year-old male patient recently diagnosed with UC who presented multiple asymptomatic vegetating pustular plaques in the bilateral groin area and multiple pustules on both upper and lower gingiva, lips and hard palate. In a rare manifestation of PDV-PSV, both upper and lower eyelids developed pustules and ulcers, predominantly affecting the left eye. Empirical antimicrobial therapies were initiated under the suspicion of an infectious etiology; however, no clinical improvement was observed. Histopathological evaluation revealed intraepidermal eosinophilic abscess with mild acantholysis and suprabasal clefting, and direct immunofluorescence study was negative supporting the diagnosis of PDV-PSV in the context of UC. The patient was successfully treated with Azathioporine and Adalimumab with significant improvement in gastrointestinal symptoms and mucocutaneous lesions after three months of therapy.
This case highlights the importance of considering PDV-PSV in UC patients who developed atypical mucocutaneous manifestations, especially when standard treatment regimen for supposed infectious etiologies fail. Although uncommon, eyelid involvement should be considered as a potential manifestation of PDV-PSV. Histopathological evaluation and direct immunofluorescence study remains essential for diagnosis, especially in cases presenting with unusual manifestations.
Consideration of PDV-PSV as a mucocutaneous manifestation of UC is essential to avoid misdiagnoses and prevent unnecessary treatments. While periocular involvement may be rare, the presence of typical skin and oral lesions, along with distinctive histological and immunofluorescence findings, should guide clinicians toward the correct diagnosis.
DOI: 10.6084/m9.figshare.29712863.v1
title: Supplementary Material for: Pyodermatitis-Pyostomatitis Vegetans with eyelid Involvement: A Rare Manifestation in a Patient with Ulcerative Colitis

description: Pyodermatitis-pyostomatitis vegetans (PDV-PSV) is a rare and chronic mucocutaneous inflammatory disorder strongly associated with inflammatory bowel disease (IBD), particularly ulcerative colitis (UC). It typically presents with exudative plaques that may affect the face, scalp, and intertriginous areas and also pustular lesions on the oral mucosa. Although several cases with cutaneous and mucosal involvement have been reported, Eyelid involvement remains uncommon and sparsely reported in the literature.
We report a 28-year-old male patient recently diagnosed with UC who presented multiple asymptomatic vegetating pustular plaques in the bilateral groin area and multiple pustules on both upper and lower gingiva, lips and hard palate. In a rare manifestation of PDV-PSV, both upper and lower eyelids developed pustules and ulcers, predominantly affecting the left eye. Empirical antimicrobial therapies were initiated under the suspicion of an infectious etiology; however, no clinical improvement was observed. Histopathological evaluation revealed intraepidermal eosinophilic abscess with mild acantholysis and suprabasal clefting, and direct immunofluorescence study was negative supporting the diagnosis of PDV-PSV in the context of UC. The patient was successfully treated with Azathioporine and Adalimumab with significant improvement in gastrointestinal symptoms and mucocutaneous lesions after three months of therapy.
This case highlights the importance of considering PDV-PSV in UC patients who developed atypical mucocutaneous manifestations, especially when standard treatment regimen for supposed infectious etiologies fail. Although uncommon, eyelid involvement should be considered as a potential manifestation of PDV-PSV. Histopathological evaluation and direct immunofluorescence study remains essential for diagnosis, especially in cases presenting with unusual manifestations.
Consideration of PDV-PSV as a mucocutaneous manifestation of UC is essential to avoid misdiagnoses and prevent unnecessary treatments. While periocular involvement may be rare, the presence of typical skin and oral lesions, along with distinctive histological and immunofluorescence findings, should guide clinicians toward the correct diagnosis.
DOI: 10.6084/m9.figshare.29712866
title: Supplementary Material for: IgG-Fc-glycosylation and a novel flowcytometric assay to predict Hemolytic Disease of the Fetus and Newborn

description: Introduction: Timely and accurate referral of pregnancies with red blood cell (RBC) alloantibodies is essential to prevent perinatal death or long-term adverse consequences in hemolytic disease of the fetus and newborn (HDFN). Classically, antibody titers are used to select high-risk pregnancies. Research suggested that also IgG-Fc-fucosylation could be an important pathological feature. We evaluated the diagnostic potential of IgG-Fc-fucosylation in identifying high-risk pregnancies, and we report on a flowcytometric assay that integrates antibody quantity, antibody subclass and fetal FcγRIIIa affinity. 

Methods: Maternal serum samples from a nationwide prospective cohort of D-alloimmunized pregnancies, between 2014 and 2017, were used to evaluate IgG-Fc-glycosylation in mass-spectrometry (n=64), and the flowcytometric assay (n=90). Results were compared to standard-of-care titers and antibody-dependent cellular-cytotoxicity assay (ADCC) results. Receiver operating curves (ROC) were used to assess and quantify predictive values. 

Results: The cohort for mass-spectrometry analysis consisted of 31 pregnancies without transfusions (48%), 16 with IUT (25%) and 17 (27%) with postnatal transfusions only. The flowcytometric assay consisted of 53 (59%) pregnancies without transfusions, 17 (19%) pregnancies with IUT, and 20 (22%) pregnancies with postnatal transfusions only, suggesting that severe HDFN was overrepresented. Anti-D IgG1 and IgG3-Fc-fucosylation levels were lower in groups requiring transfusions, but no distinct difference between groups was detected. No significant difference in other glycan traits was found. Among sera from 90 D-alloimmunized pregnancies evaluated in the flowcytometric assay, we found significant differences in IgG- and FcγRIIIa binding between pregnancies without transfusions and with IUT, suggesting a potential predictive value for the need for IUTs. ROC analyses revealed a lower false-positive rate at a 100% sensitivity in the prediction of pregnancies at-risk for fetal anemia through the flowcytometric assay (20.8% for IgG binding and 43.1% for FcγRIIIa binding) compared to the titer and ADCC (74.6%).

Conclusion: Anti-D IgG-Fc-fucosylation levels tended to be lower in pregnancies with IUT, but could not distinguish pregnancies with or without IUT in this cohort. The flowcytometric assay, measuring IgG levels and functional FcγRIIIa binding, indicates that the specificity of serological monitoring in HDFN may be improved. Considering an overrepresentation of severe HDFN in this cohort, we advise to confirm these findings in a prospective cohort within a routine setting.
DOI: 10.6084/m9.figshare.29712866.v1
title: Supplementary Material for: IgG-Fc-glycosylation and a novel flowcytometric assay to predict Hemolytic Disease of the Fetus and Newborn

description: Introduction: Timely and accurate referral of pregnancies with red blood cell (RBC) alloantibodies is essential to prevent perinatal death or long-term adverse consequences in hemolytic disease of the fetus and newborn (HDFN). Classically, antibody titers are used to select high-risk pregnancies. Research suggested that also IgG-Fc-fucosylation could be an important pathological feature. We evaluated the diagnostic potential of IgG-Fc-fucosylation in identifying high-risk pregnancies, and we report on a flowcytometric assay that integrates antibody quantity, antibody subclass and fetal FcγRIIIa affinity. 

Methods: Maternal serum samples from a nationwide prospective cohort of D-alloimmunized pregnancies, between 2014 and 2017, were used to evaluate IgG-Fc-glycosylation in mass-spectrometry (n=64), and the flowcytometric assay (n=90). Results were compared to standard-of-care titers and antibody-dependent cellular-cytotoxicity assay (ADCC) results. Receiver operating curves (ROC) were used to assess and quantify predictive values. 

Results: The cohort for mass-spectrometry analysis consisted of 31 pregnancies without transfusions (48%), 16 with IUT (25%) and 17 (27%) with postnatal transfusions only. The flowcytometric assay consisted of 53 (59%) pregnancies without transfusions, 17 (19%) pregnancies with IUT, and 20 (22%) pregnancies with postnatal transfusions only, suggesting that severe HDFN was overrepresented. Anti-D IgG1 and IgG3-Fc-fucosylation levels were lower in groups requiring transfusions, but no distinct difference between groups was detected. No significant difference in other glycan traits was found. Among sera from 90 D-alloimmunized pregnancies evaluated in the flowcytometric assay, we found significant differences in IgG- and FcγRIIIa binding between pregnancies without transfusions and with IUT, suggesting a potential predictive value for the need for IUTs. ROC analyses revealed a lower false-positive rate at a 100% sensitivity in the prediction of pregnancies at-risk for fetal anemia through the flowcytometric assay (20.8% for IgG binding and 43.1% for FcγRIIIa binding) compared to the titer and ADCC (74.6%).

Conclusion: Anti-D IgG-Fc-fucosylation levels tended to be lower in pregnancies with IUT, but could not distinguish pregnancies with or without IUT in this cohort. The flowcytometric assay, measuring IgG levels and functional FcγRIIIa binding, indicates that the specificity of serological monitoring in HDFN may be improved. Considering an overrepresentation of severe HDFN in this cohort, we advise to confirm these findings in a prospective cohort within a routine setting.
DOI: 10.15468/dl.463hxv
title: Occurrence Download

description: A dataset containing 8109 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Eurynia dilatata",
 "HasGeospatialIssue is false",
 "HasCoordinate is true",
 {
 "not" : {
 "BasisOfRecord" : [
 "is Fossil"
 ]
 }
 },
 {
 "or" : [
 {
 "not" : {
 "EstablishmentMeans" : [
 "is MANAGED"
 ]
 }
 },
 {
 "not" : {
 "EstablishmentMeans" : [
 "is not null"
 ]
 }
 }
 ]
 },
 {
 "or" : [
 "OccurrenceStatus is Present",
 {
 "not" : {
 "OccurrenceStatus" : [
 "is not null"
 ]
 }
 }
 ]
 }
 ]
}

 The dataset includes 8109 records from 31 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0025642-260208012135463/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.ywnuj8
title: Occurrence Download

description: A dataset containing 181 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Country is one of (China, Chinese Taipei)",
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "TaxonKey is Dendrocalamus latiflorus Munro",
 "Year 1975-2025"
 ]
}

 The dataset includes 181 records from 10 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0007694-250415084134356/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.dtc5sn
title: Occurrence Download

description: A dataset containing 3549 species occurrences available in GBIF matching the query:
{
 "DatasetKey" : [
 "is Biological survey of lakes and reservoirs from Sardinia and Piedmont (Italy), a georeferenced dataset from the project LIFE INHABIT"
 ]
}

 The dataset includes 3549 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0007693-250415084134356/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.c995cc
title: Occurrence Download

description: A dataset containing 466 species occurrences available in GBIF matching the query:
{
 "and" : [
 "HasGeospatialIssue is false",
 "HasCoordinate is true",
 "OccurrenceStatus is Present",
 {
 "not" : {
 "BasisOfRecord" : [
 "is one of (Fossil, Living Specimen)"
 ]
 }
 },
 "TaxonKey is Acanthosyris (Eichl.) Griseb."
 ]
}

 The dataset includes 466 records from 45 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0010516-250426092105405/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.25549/rbm-ouc11987005
title: The North American Indian, vol. 6 supplement

description: 36 plates supplementing volume six of The North American Indian.
DOI: 10.25549/rbm-ouc11987490
title: The North American Indian, vol. 10 supplement

description: 36 plates supplementing volume ten of The North American Indian.
DOI: 10.25549/rbm-ouc11987452
title: The North American Indian, vol. 11 supplement

description: 36 plates supplementing volume eleven of The North American Indian.
DOI: 10.25549/rbm-ouc11987461
title: The North American Indian, vol. 11 supplement

description: 36 plates supplementing volume eleven of The North American Indian.
DOI: 10.25549/rbm-ouc11987625
title: The North American Indian, vol. 11 supplement

description: 36 plates supplementing volume eleven of The North American Indian.
DOI: 10.25549/rbm-ouc11987679
title: The North American Indian, vol. 11 supplement

description: 36 plates supplementing volume eleven of The North American Indian.
DOI: 10.25549/rbm-ouc11987003
title: The North American Indian, vol. 7 supplement

description: 36 plates supplementing volume six of The North American Indian.
DOI: 10.25549/rbm-ouc11986973
title: The North American Indian, vol. 7 supplement

description: 36 plates supplementing volume six of The North American Indian.
DOI: 10.25549/rbm-ouc11987202
title: The North American Indian, vol. 7 supplement

description: 36 plates supplementing volume six of The North American Indian.
DOI: 10.5281/zenodo.18795106
title: Agro-Ecological Zones (AEZ) spatial dataset for biodiversity analysis

description: This dataset contains spatial boundaries of Agro-Ecological Zones (AEZs)used for spatial aggregation and environmental analysis in thecs3-biodiversity research project.

The shapefile defines ecological production zones characterized byclimate, soil, and terrain constraints relevant to agricultural andland-use analysis.

The dataset is provided as an ESRI Shapefile with accompanyingdocumentation describing provenance and usage.
DOI: 10.5281/zenodo.18795105
title: Agro-Ecological Zones (AEZ) spatial dataset for biodiversity analysis

description: This dataset contains spatial boundaries of Agro-Ecological Zones (AEZs)used for spatial aggregation and environmental analysis in thecs3-biodiversity research project.

The shapefile defines ecological production zones characterized byclimate, soil, and terrain constraints relevant to agricultural andland-use analysis.

The dataset is provided as an ESRI Shapefile with accompanyingdocumentation describing provenance and usage.
DOI: 10.25549/rbm-ouc11986976
title: The North American Indian, vol. 7 supplement

description: 36 plates supplementing volume six of The North American Indian.
DOI: 10.25549/rbm-ouc11986979
title: The North American Indian, vol. 7 supplement

description: 36 plates supplementing volume six of The North American Indian.